Home / Authors

Authors & reviewers

The people accountable for Tirzepatide Watchdog content.

Jonathan Snipes, MD

Medical Reviewer

Kim Callender, NP, FNP-BC

Lead Clinical Reviewer

Dr. Parmis Mojarab, DO

Independent Score Auditor and Lead Medical Researcher

SURMOUNT-1 — mean body-weight reduction by tirzepatide dose, 72 weeks
06111723Placebo3%Tirzepatide 5mg15%Tirzepatide 10mg20%Tirzepatide 15mg21%

Jastreboff AM et al., N Engl J Med 2022 (NCT04184622), n=2,539. Dose-response is real: the effect rises with dose. These are FDA-APPROVED SUBCUTANEOUS INJECTION doses — they do not transfer to compounded, microdose or ODT products. Trial means are not individual promises.